Kumar N - Search Results

1

Intraoperative cell-salvaged autologous blood transfusion is safe in metastatic spine tumour surgery: early outcomes of prospective clinical study.

Kumar N, Tan JYH, Chen Z, Ravikumar N, Milavec H, Tan JH. Kumar N, et al. Eur Spine J. 2023 Jul;32(7):2493-2502. doi: 10.1007/s00586-023-07768-4. Epub 2023 May 16. Eur Spine J. 2023. PMID: 37191676

2

What is the role of autologous blood transfusion in major spine surgery?

Kumar N, Chen Y, Nath C, Liu EH. Kumar N, et al. Am J Orthop (Belle Mead NJ). 2012 Jun;41(6):E89-95. Am J Orthop (Belle Mead NJ). 2012. PMID: 22837998 Review.

3

Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review.

Kumar N, Chen Y, Zaw AS, Nayak D, Ahmed Q, Soong R, Wong HK. Kumar N, et al. Lancet Oncol. 2014 Jan;15(1):e33-41. doi: 10.1016/S1470-2045(13)70245-6. Lancet Oncol. 2014. PMID: 24384492 Review.

4

Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery.

Kumar N, Lam R, Zaw AS, Malhotra R, Tan J, Tan G, Setiobudi T. Kumar N, et al. Ann Surg Oncol. 2014 Dec;21(13):4330-5. doi: 10.1245/s10434-014-3950-9. Epub 2014 Jul 29. Ann Surg Oncol. 2014. PMID: 25069862

5

Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?

Kumar N, Ahmed Q, Lee VK, Zaw AS, Goy R, Wong HK. Kumar N, et al. Eur Spine J. 2016 Dec;25(12):3997-4007. doi: 10.1007/s00586-015-4112-x. Epub 2015 Jul 19. Eur Spine J. 2016. PMID: 26188770

6

Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells.

Kumar N, Zaw AS, Khoo BL, Nandi S, Lai Z, Singh G, Lim CT, Thiery JP. Kumar N, et al. Eur Spine J. 2016 Dec;25(12):4008-4015. doi: 10.1007/s00586-016-4478-4. Epub 2016 Mar 7. Eur Spine J. 2016. PMID: 26951173

7

The role of preoperative vascular embolization in surgery for metastatic spinal tumours.

Kumar N, Tan B, Zaw AS, Khine HE, Maharajan K, Lau LL, Rajendran PC, Gopinathan A. Kumar N, et al. Eur Spine J. 2016 Dec;25(12):3962-3970. doi: 10.1007/s00586-016-4494-4. Epub 2016 Mar 11. Eur Spine J. 2016. PMID: 26968873

8

Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer.

Tan JH, Tan KA, Zaw AS, Thomas AC, Hey HW, Soo RA, Kumar N. Tan JH, et al. Among authors: kumar n. Spine (Phila Pa 1976). 2016 Apr;41(7):638-44. doi: 10.1097/BRS.0000000000001279. Spine (Phila Pa 1976). 2016. PMID: 27018903

9

The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients With Spinal Metastases.

Kumar N, Tan KA, Tan JH, Zaw AS, Hey HWD, Ruiz J, Stone E. Kumar N, et al. Clin Spine Surg. 2018 Feb;31(1):E1-E7. doi: 10.1097/BSD.0000000000000475. Clin Spine Surg. 2018. PMID: 27875414

10

Evaluation of Prognostic Factors and Proposed Changes to the Modified Tokuhashi Score in Patients With Spinal Metastases From Breast Cancer.

Tan KA, Tan JH, Zaw AS, Tan JYH, Hey HWD, Kumar N. Tan KA, et al. Among authors: kumar n. Spine (Phila Pa 1976). 2018 Apr 1;43(7):512-519. doi: 10.1097/BRS.0000000000002350. Spine (Phila Pa 1976). 2018. PMID: 28749856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,437 results

Search Page

Filters